Low triiodothyronine and survival in end-stage renal disease

  • Zoccali C
  • Mallamaci F
  • Tripepi G
 et al. 
  • 22

    Readers

    Mendeley users who have this article in their library.
  • 102

    Citations

    Citations of this article.

Abstract

Plasma triiodothyronine (fT3) is a strong predictor of adverse clinical outcomes in various clinical conditions. Since fT3 in patients with end-stage renal diseases (ESRD) is frequently reduced and is associated with inflammation and cardiovascular damage, we prospectively tested the hypothesis that it predicts death in a cohort of 200 hemodialysis patients. Plasma fT3 was lower in ESRD patients (P

Author-supplied keywords

  • ESRD
  • Epidemiology
  • Risk
  • Survival
  • T3
  • Thyroid
  • Uremia

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • Carmine ZoccaliInstitute of Clinical Physiology Reggio Calabria Branch National Research Council

    Follow
  • Giovanni TripepiInstitute of Clinical Physiology Reggio Calabria Branch National Research Council

    Follow
  • F. Mallamaci

  • S. Cutrupi

  • P. Pizzini

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free